SelectQuote, Inc. received a notice from the NYSE on March 19, 2026, stating non-compliance with Section 802.01C of the NYSE Listed Company Manual due to its common stock's average closing price below $1.00 over a 30 trading-day period. The Company intends to cure the deficiency within the six-month period while its stock continues trading on the NYSE.
Key takeaways
Received NYSE notice on March 19, 2026, for non-compliance with Section 802.01C.
Average closing price of common stock less than $1.00 over consecutive 30 trading-day period.
Six-month cure period to regain compliance by achieving closing price and 30-day average of at least $1.00 on last trading day of any calendar month.
Notified NYSE of intent to cure and will monitor stock price and consider alternatives.
Common stock continues to be listed and traded on NYSE during cure period, subject to other standards.
Projects fiscal 2026 operating cash flow in range of $25 million to $35 million.